Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Primary Care
•
Geriatric Medicine
In adults ≥80 years with TSH 6–10 mIU/L and minimal symptoms, do you initiate levothyroxine, monitor, or avoid treatment entirely? Does frailty change your threshold?
Related Questions
In older adults with mild cognitive impairment, do you ever prescribe cholinesterase inhibitors and/or memantine?
How do you counsel patients who are concerned that discontinuation of certain chronic medications may actually perpetuate suffering at the end of life?
In older adults with chronic mild hyponatremia (Na 128–132) attributed to SSRIs but good psychiatric response, do you tolerate persistent hyponatremia, reduce the dose, or switch agents? At what sodium level do you intervene?
What are your thoughts about lion's mane supplementation to slow the decline or improve cognitive capacity for those at risk of dementia?
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
Do you routinely adjust your interpretation of SLUMS and/or MOCA tests in patients depending on their level of education?
What practical next steps would you recommend once identifying loneliness in an older adult patient?
How would you approach consideration to continuing or ceasing colonoscopy for colon cancer screening in a relatively fit 82 year-old-man without a history of polyps on prior colonoscopies?
How do you approach choice of pharmacological therapy when treating insomnia in older adults in the outpatients setting with a high falling risk?
What is your approach to deprescribing gabapentinoids so as to prevent withdrawal effects?
